Tear Film Stability of DAILIES® AquaComfort Plus® Contact Lenses vs. MyDay® Daily Disposable Contact Lenses
NCT ID: NCT02089191
Last Updated: 2015-05-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
31 participants
INTERVENTIONAL
2014-03-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tear Film Evaluation of Dailies® AquaComfort Plus® Multifocal and Toric
NCT02289742
Visual Assessment of DAILIES® AquaComfort Plus® for Astigmatism as Compared to 1-DAY ACUVUE® MOIST® for Astigmatism
NCT02071771
Comparison of Two Daily Disposable Lenses
NCT04013789
Comparative Evaluation of Contact Lens Centering of DAILIES® AquaComfort Plus® Versus 1-DAY ACUVUE® MOIST® in Japan
NCT02103309
Pre-Lens Tear Film Performance of Silicone Hydrogel Daily Disposable Contact Lenses
NCT01548833
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DACP/MyDay
Nelfilcon A contact lenses worn in Period 1, with stenfilcon A contact lenses in Period 2. Each product worn bilaterally for 12 hours over 1 day.
Nelfilcon A contact lenses
Stenfilcon A contact lenses
MyDay/DACP
Stenfilcon A contact lenses worn in Period 1, with nelfilcon A contact lenses in Period 2. Each product worn bilaterally for 12 hours over 1 day.
Nelfilcon A contact lenses
Stenfilcon A contact lenses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nelfilcon A contact lenses
Stenfilcon A contact lenses
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adapted, current soft contact lens wearer;
* Required contact lens prescription within the power range specified in the protocol (+6.00 to -10.00 diopters (D));
* Cylinder ≤ -1.00 D in both eyes at Visit 1;
* Vision correctable to 0.1 logarithm of the Minimum Angle of Resolution (logMAR) or better in each eye at distance with pre-study lenses at Visit 1;
* Willing to wear study lenses up to 12 hours and attend all study visits;
* Able to be successfully fitted with study lenses;
* Unstable tear film with a NIK-BUT value below 13 seconds in either eye without lenses;
Exclusion Criteria
* Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator;
* Use of artificial tears and rewetting drops during the study;
* Monocular (only 1 eye with functional vision) or fit with only 1 lens;
* Any abnormal ocular condition observed during Visit 1;
* History of herpetic keratitis, ocular surgery, or irregular cornea;
* Pregnant or lactating;
* Participation in any clinical study within 30 days of Visit 1;
* Current MyDay® or DAILIES® AquaComfort Plus® lens wearer;
18 Years
44 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Global Medical Affairs, Clinical Manager, Vision Care
Role: STUDY_DIRECTOR
Alcon Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alcon Investigative Site
Jena, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M-14-006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.